All Stories

  1. 3D printed system using ex vivo porcine eye globes to investigate intracorneal absorption of dexpanthenol from contact lens care solution and eye drops

    Article • International Journal of Pharmaceutics X, June 2026, Elsevier

    Prof Yogeshvar Kalia

  2. Comparing the efficacy of nanocarriers for cutaneous and follicular delivery of poorly water-soluble molecules: A case study with ciclosporin A

    Article • International Journal of Pharmaceutics X, June 2026, Elsevier

    Prof Yogeshvar Kalia

  3. Biologically engineered vectors enable topical mRNA delivery for skin regeneration

    Article • April 2026, Springer Science + Business Media

    Prof Yogeshvar Kalia

  4. In Vitro Evaluation of Topical Follicular Delivery of Minoxidil and Latanoprost Co-Entrapped in Lipid Nanocarriers

    Article • February 2026, MDPI AG

    Prof Yogeshvar Kalia

  5. Bioanalytical UHPLC–MS/MS Method for Quantification of Terbinafine in Ungual Delivery Studies

    Article • Biomedical Chromatography, February 2026, Wiley

    Prof Yogeshvar Kalia

  6. Iontophoretic delivery of caspofungin acetate to the cornea and sclera and its intracorneal biodistribution

    Article • International Journal of Pharmaceutics X, December 2025, Elsevier

    Prof Yogeshvar Kalia

  7. Cutaneous delivery and biodistribution of a lipophilic natural product – bakuchiol: Comparing nanocarrier performance

    Article • International Journal of Pharmaceutics, August 2025, Elsevier

    Prof Yogeshvar Kalia

  8. Trends and Commonalities of Approved and Late Clinical-Phase RNA Therapeutics

    Article • Pharmaceutics, July 2025, MDPI AG

    Prof Yogeshvar Kalia

  9. Development of an ex vivo human skin model and evaluation of biological responses to subcutaneously injected hyaluronic acid formulations

    Article • International Journal of Pharmaceutics, April 2025, Elsevier

    Prof Yogeshvar Kalia

  10. Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration

    Article • Pharmaceutics, April 2024, MDPI AG

    Prof Yogeshvar Kalia

  11. Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations

    Article • Pharmaceutics, January 2024, MDPI AG

    Prof Yogeshvar Kalia

  12. Clinical Perspectives on the Injectability of Cross-Linked Hyaluronic Acid Dermal Fillers: A Standardized Methodology for Commercial Product Benchmarking with Inter-Injector Assessments

    Article • Gels, January 2024, MDPI AG

    Prof Yogeshvar Kalia

  13. Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model

    Article • Pharmaceutics, January 2024, MDPI AG

    Prof Yogeshvar Kalia, Pr. Fabien Gosselet

  14. Development of an ex vivo porcine skin model for the preclinical evaluation of subcutaneously injected biomacromolecules

    Article • International Journal of Pharmaceutics, December 2023, Elsevier

    Prof Yogeshvar Kalia

  15. Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches

    Article • International Journal of Pharmaceutics, December 2023, Elsevier

    Prof Yogeshvar Kalia

  16. Polymeric micelles for cutaneous delivery of the hedgehog pathway inhibitor TAK-441: Formulation development and cutaneous biodistribution in porcine and human skin

    Article • International Journal of Pharmaceutics, September 2023, Elsevier

    Prof Yogeshvar Kalia

  17. Injectable Hyaluronan-Based Thermoresponsive Hydrogels for Dermatological Applications

    Article • Pharmaceutics, June 2023, MDPI AG

    Prof Yogeshvar Kalia

  18. Influence of Molecular Structure and Physicochemical Properties of Immunosuppressive Drugs on Micelle Formulation Characteristics and Cutaneous Delivery

    Article • Pharmaceutics, April 2023, MDPI AG

    Prof Yogeshvar Kalia

  19. Non-Invasive Iontophoretic Delivery of Cytochrome c to the Posterior Segment and Determination of Its Ocular Biodistribution

    Article • Pharmaceutics, August 2022, MDPI AG

    Prof Yogeshvar Kalia

  20. Simultaneous Delivery of Econazole, Terbinafine and Amorolfine with Improved Cutaneous Bioavailability: A Novel Micelle-Based Antifungal “Tri-Therapy”

    Article • Pharmaceutics, January 2022, MDPI AG

    Prof Yogeshvar Kalia

  21. Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression

    Article • Pharmaceutics, January 2022, MDPI AG

    Prof Yogeshvar Kalia

  22. Controlled simultaneous iontophoresis of buflomedil hydrochloride and dexamethasone sodium phosphate to the mucosa for oral submucous fibrosis

    Article • International Journal of Pharmaceutics, September 2021, Elsevier

    Prof Yogeshvar Kalia

  23. DESI-MS imaging to visualize spatial distribution of xenobiotics and endogenous lipids in the skin

    Article • International Journal of Pharmaceutics, September 2021, Elsevier

    Prof Yogeshvar Kalia

  24. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2021, Elsevier

    Prof Yogeshvar Kalia

  25. Using Porcine Jejunum Ex Vivo to Study Absorption and Biotransformation of Natural Products in Plant Extracts: Pueraria lobata as a Case Study

    Article • Metabolites, August 2021, MDPI AG

    Prof Yogeshvar Kalia

  26. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson’s therapy

    Article • European Journal of Pharmaceutics and Biopharmaceutics, August 2021, Elsevier

    Prof Yogeshvar Kalia

  27. Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing

    Article • International Journal of Pharmaceutics, July 2021, Elsevier

    Prof Yogeshvar Kalia

  28. Polymeric micelle formulations for the cutaneous delivery of sirolimus: A new approach for the treatment of facial angiofibromas in tuberous sclerosis complex

    Article • International Journal of Pharmaceutics, July 2021, Elsevier

    Prof Yogeshvar Kalia

  29. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants

    Article • International Journal of Pharmaceutics, June 2021, Elsevier

    Prof Yogeshvar Kalia

  30. Effect of continuous and multi-phasic current profiles on the iontophoretic transport of pramipexole, rasagiline and huperzine A: Depicting temporal variation and biodistribution in the skin

    Article • International Journal of Pharmaceutics, April 2021, Elsevier

    Prof Yogeshvar Kalia

  31. Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapy

    Article • Nanomedicine Nanotechnology Biology and Medicine, April 2021, Elsevier

    Prof Yogeshvar Kalia

  32. Iontosomes: Electroresponsive Liposomes for Topical Iontophoretic Delivery of Chemotherapeutics to the Buccal Mucosa

    Article • Pharmaceutics, January 2021, MDPI AG

    Prof Yogeshvar Kalia

  33. Using protease inhibitors to improve protein stability in the presence of skin: A case study on the stability of insulin like growth factor 1

    Article • European Journal of Pharmaceutics and Biopharmaceutics, January 2021, Elsevier

    Prof Yogeshvar Kalia

  34. Withdrawal notice to ‘WITHDRAWN: Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue’ [International Journal of Pharmaceutics 589 (2020) 119913]

    Article • International Journal of Pharmaceutics X, December 2020, Elsevier

    Prof Yogeshvar Kalia

  35. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue

    Article • International Journal of Pharmaceutics, November 2020, Elsevier

    Prof Yogeshvar Kalia

  36. Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early—Stage Drug Development

    Article • Biomedicines, September 2020, MDPI AG

    Prof Yogeshvar Kalia

  37. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1B and a poly-ARG interferon beta-1B analogue

    Article • International Journal of Pharmaceutics X, July 2020, Elsevier

    Prof Yogeshvar Kalia

  38. Tissue Levels of Flurbiprofen in the Rat Plantar Heel after Short-Duration Topical Iontophoresis are Sufficient to Induce Pharmacodynamic Responses to Local Pain Stimuli

    Article • Pharmaceutics, June 2020, MDPI AG

    Prof Yogeshvar Kalia

  39. Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation

    Article • International Journal of Pharmaceutics, April 2020, Elsevier

    Prof Yogeshvar Kalia

  40. Non-invasive targeted iontophoretic delivery of cetuximab to skin

    Article • Expert Opinion on Drug Delivery, February 2020, Taylor & Francis

    Prof Yogeshvar Kalia

  41. Ocular Biodistribution of Spironolactone after a Single Intravitreal Injection of a Biodegradable Sustained-Release Polymer in Rats

    Article • Molecular Pharmaceutics, December 2019, American Chemical Society (ACS)

    Prof Yogeshvar Kalia

  42. Cutaneous Biodistribution: A High-Resolution Methodology to Assess Bioequivalence in Topical Skin Delivery

    Article • Pharmaceutics, September 2019, MDPI AG

    Prof Yogeshvar Kalia

  43. Topical iontophoresis of buflomedil hydrochloride increases drug bioavailability in the mucosa: A targeted approach to treat oral submucous fibrosis

    Article • International Journal of Pharmaceutics, August 2019, Elsevier

    Prof Yogeshvar Kalia

  44. Using ordered mesoporous silica sba-15 to limit cutaneous penetration and transdermal permeation of organic uv filters

    Article • International Journal of Pharmaceutics, August 2019, Elsevier

    Prof Yogeshvar Kalia

  45. Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140—A Multitarget Compound for Alzheimer’s Disease

    Article • Molecular Pharmaceutics, July 2019, American Chemical Society (ACS)

    Prof Yogeshvar Kalia

  46. Er:YAG fractional laser ablation for cutaneous co-delivery of pentoxifylline and d-α-tocopherol succinate: A new approach for topical treatment of radiation-induced skin fibrosis

    Article • European Journal of Pharmaceutical Sciences, July 2019, Elsevier

    Prof Yogeshvar Kalia

  47. Delivering vismodegib directly to the skin

    Article • Expert Opinion on Drug Delivery, April 2019, Taylor & Francis

    Prof Yogeshvar Kalia

  48. Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption

    Article • Pharmaceutics, March 2019, MDPI AG

    Prof Yogeshvar Kalia

  49. Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966

    Article • Scientific Reports, January 2019, Springer Science + Business Media

    Prof Yogeshvar Kalia

  50. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod

    Article • European Journal of Pharmaceutics and Biopharmaceutics, January 2019, Elsevier

    Prof Yogeshvar Kalia

  51. Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases

    Article • Expert Opinion on Drug Delivery, December 2018, Taylor & Francis

    Prof Yogeshvar Kalia

  52. Investigation of Different Iontophoretic Currents Profiles for Short-Term Applications in Cosmetics

    Article • Pharmaceutics, December 2018, MDPI AG

    Prof Yogeshvar Kalia

  53. Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye

    Article • European Journal of Pharmaceutics and Biopharmaceutics, November 2018, Elsevier

    Prof Yogeshvar Kalia

  54. Hyaluronic Acid After Subcutaneous Injection—An Objective Assessment

    Article • Dermatologic Surgery, July 2018, Wolters Kluwer Health

    Prof Yogeshvar Kalia

  55. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo : Transdermal polypharmacy to treat Parkinson’s disease

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2018, Elsevier

    Prof Yogeshvar Kalia

  56. Hydrogels in three-dimensional dendritic cell (MUTZ-3) culture as a scaffold to mimic human immuno competent subcutaneous tissue

    Article • International Journal of Pharmaceutics, June 2018, Elsevier

    Prof Yogeshvar Kalia

  57. Needle-free cutaneous delivery of living human cells by Er:YAG fractional laser ablation

    Article • Expert Opinion on Drug Delivery, May 2018, Taylor & Francis

    Prof Yogeshvar Kalia

  58. Development and validation of a fast and sensitive UHPLC-ESI-MS method for the simultaneous quantification of spironolactone and its metabolites in ocular tissues.

    Article • Biomedical Chromatography, May 2018, Wiley

    Prof Yogeshvar Kalia

  59. Topical Administration of Spironolactone-Loaded Nanomicelles Prevents Glucocorticoid-Induced Delayed Corneal Wound Healing in Rabbits

    Article • Molecular Pharmaceutics, February 2018, American Chemical Society (ACS)

    Prof Yogeshvar Kalia

  60. Selective delivery of adapalene to the human hair follicle under finite dose conditions using polymeric micelle nanocarriers

    Article • Nanoscale, January 2018, Royal Society of Chemistry

    Prof Yogeshvar Kalia

  61. Short-duration ocular iontophoresis of ionizable aciclovir prodrugs: A new approach to treat herpes simplex infections in the anterior and posterior segments of the eye

    Article • International Journal of Pharmaceutics, January 2018, Elsevier

    Prof Yogeshvar Kalia

  62. Targeted intracorneal delivery—Biodistribution of triamcinolone acetonide following topical iontophoresis of cationic amino acid ester prodrugs

    Article • International Journal of Pharmaceutics, June 2017, Elsevier

    Prof Yogeshvar Kalia

  63. Formulation challenges for 21st century topical and transdermal delivery systems

    Article • Expert Opinion on Drug Delivery, March 2017, Taylor & Francis

    Prof Yogeshvar Kalia

  64. Cutaneous iontophoresis of μ-conotoxin CnIIIC—A potent NaV1.4 antagonist with analgesic, anaesthetic and myorelaxant properties

    Article • International Journal of Pharmaceutics, February 2017, Elsevier

    Prof Yogeshvar Kalia

  65. Transdermal therapeutic systems for memantine delivery. Comparison of passive and iontophoretic transport

    Article • International Journal of Pharmaceutics, January 2017, Elsevier

    Prof Yogeshvar Kalia

  66. Basic principles and current status of transcorneal and transscleral iontophoresis

    Article • Expert Opinion on Drug Delivery, December 2016, Taylor & Francis

    Prof Yogeshvar Kalia

  67. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis

    Article • Journal of Controlled Release, November 2016, Elsevier

    Prof Yogeshvar Kalia

  68. Erratum to “Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability” [Eur. J. Pharm. Biopharm. 99 (2016) 103–113]

    Article • European Journal of Pharmaceutics and Biopharmaceutics, May 2016, Elsevier

    Prof Yogeshvar Kalia

  69. Topical delivery of diclofenac into and across equine skin from a novel liquid diclofenac epolamine formulation

    Article • Journal of Veterinary Pharmacology and Therapeutics, March 2016, Wiley

    Prof Yogeshvar Kalia

  70. Controlled transdermal iontophoresis for poly-pharmacotherapy: Simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo

    Article • European Journal of Pharmaceutical Sciences, March 2016, Elsevier

    Prof Yogeshvar Kalia

  71. A UHPLC-UV Method to Quantify Skin Deposition and Transdermal Permeation of Tizanidine Hydrochloride

    Article • Journal of Chromatographic Science, February 2016, Oxford University Press (OUP)

    Prof Yogeshvar Kalia

  72. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery

    Article • European Journal of Pharmaceutics and Biopharmaceutics, February 2016, Elsevier

    Prof Yogeshvar Kalia

  73. Fractional Laser Ablation for the Cutaneous Delivery of Triamcinolone Acetonide from Cryomilled Polymeric Microparticles: Creating Intraepidermal Drug Depots

    Article • Molecular Pharmaceutics, February 2016, American Chemical Society (ACS)

    Prof Yogeshvar Kalia

  74. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability

    Article • European Journal of Pharmaceutics and Biopharmaceutics, February 2016, Elsevier

    Prof Yogeshvar Kalia

  75. Polymeric Micelles in Dermal and Transdermal Delivery

    Article • January 2016, Springer Science + Business Media

    Prof Yogeshvar Kalia

  76. Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities

    Article • Bioorganic & Medicinal Chemistry Letters, April 2015, Elsevier

    Prof Yogeshvar Kalia

  77. Transdermal patches: history, development and pharmacology

    Article • Bone Marrow Transplantation, March 2015, Wiley

    Prof Yogeshvar Kalia

  78. Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle

    Article • Nanoscale, January 2015, Royal Society of Chemistry

    Prof Yogeshvar Kalia

  79. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways

    Article • Journal of Controlled Release, December 2014, Elsevier

    Prof Yogeshvar Kalia

  80. Colloidal Soft Nanocarrier for Transdermal Delivery of Dopamine Agonist: Ex Vivo and In Vivo Evaluation

    Article • Journal of Biomedical Nanotechnology, November 2014, American Scientific Publishers

    Prof Yogeshvar Kalia

  81. Polymeric Micelle Nanocarriers for the Cutaneous Delivery of Tacrolimus: A Targeted Approach for the Treatment of Psoriasis

    Article • Molecular Pharmaceutics, September 2014, American Chemical Society (ACS)

    Prof Yogeshvar Kalia

  82. Controlled iontophoretic delivery of pramipexole: Electrotransport kinetics in vitro and in vivo

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2014, Elsevier

    Prof Yogeshvar Kalia

  83. Understanding the poor iontophoretic transport of lysozyme across the skin: When high charge and high electrophoretic mobility are not enough

    Article • Journal of Controlled Release, June 2014, Elsevier

    Prof Yogeshvar Kalia

  84. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: Demonstrating local enhanced topical drug delivery to muscle

    Article • European Journal of Pharmaceutics and Biopharmaceutics, February 2014, Elsevier

    Prof Yogeshvar Kalia

  85. Targeted local simultaneous iontophoresis of chemotherapeutics for topical therapy of head and neck cancers

    Article • International Journal of Pharmaceutics, January 2014, Elsevier

    Prof Yogeshvar Kalia

  86. Next generation intra- and transdermal therapeutic systems: Using non- and minimally-invasive technologies to increase drug delivery into and across the skin

    Article • European Journal of Pharmaceutical Sciences, December 2013, Elsevier

    Prof Yogeshvar Kalia

  87. Controlled Iontophoretic Transport of Huperzine A across Skinin Vitroandin Vivo: Effect of Delivery Conditions and Comparison of Pharmacokinetic Models

    Article • Molecular Pharmaceutics, November 2013, American Chemical Society (ACS)

    Prof Yogeshvar Kalia

  88. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2013, Elsevier

    Prof Yogeshvar Kalia

  89. Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery

    Article • Expert Opinion on Drug Delivery, April 2013, Informa Healthcare

    Prof Yogeshvar Kalia

  90. Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A

    Article • International Journal of Pharmaceutics, March 2013, Elsevier

    Prof Yogeshvar Kalia

  91. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier

    Article • Advanced Drug Delivery Reviews, February 2013, Elsevier

    Prof Yogeshvar Kalia

  92. Turning Theory into Practice: The Development of Modern Transdermal Drug Delivery Systems and Future Trends

    Article • Skin Pharmacology and Physiology, January 2013, Karger Publishers

    Prof Yogeshvar Kalia

  93. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro

    Article • International Journal of Pharmaceutics, November 2012, Elsevier

    Prof Yogeshvar Kalia

  94. Transcutaneous vaccination via laser microporation

    Article • Journal of Controlled Release, September 2012, Elsevier

    Prof Yogeshvar Kalia

  95. The Pharmaceutical Biochemistry Group: Where Pharmaceutical Chemistry Meets Biology and Drug Delivery

    Article • CHIMIA International Journal for Chemistry, May 2012, Swiss Chemical Society

    Prof Yogeshvar Kalia

  96. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewisx mimetic, in vitro

    Article • Experimental Dermatology, March 2012, Wiley

    Prof Yogeshvar Kalia

  97. Clinical Applications of Transdermal Iontophoresis

    Article • January 2012, Wiley

    Prof Yogeshvar Kalia

  98. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies

    Article • Journal of Controlled Release, November 2011, Elsevier

    Prof Yogeshvar Kalia

  99. Development and validation of a HPAE-PAD method for the quantification of CGP69669A, a sialyl Lewisx mimetic, in skin permeation studies

    Article • Biomedical Chromatography, August 2011, Wiley

    Prof Yogeshvar Kalia

  100. Noninvasive Transdermal Iontophoretic Delivery of Biologically Active Human Basic Fibroblast Growth Factor

    Article • Molecular Pharmaceutics, August 2011, American Chemical Society (ACS)

    Prof Yogeshvar Kalia

  101. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications

    Article • European Journal of Pharmaceutics and Biopharmaceutics, August 2011, Elsevier

    Prof Yogeshvar Kalia

  102. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals

    Article • Journal of Controlled Release, July 2011, Elsevier

    Prof Yogeshvar Kalia

  103. Electrically-assisted delivery of an anionic protein across intact skin: Cathodal iontophoresis of biologically active ribonuclease T1

    Article • Journal of Controlled Release, June 2011, Elsevier

    Prof Yogeshvar Kalia

  104. Human growth hormone: New delivery systems, alternative routes of administration, and their pharmacological relevance

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2011, Elsevier

    Prof Yogeshvar Kalia

  105. Non-invasive iontophoretic delivery of peptides and proteins across the skin

    Article • Expert Opinion on Drug Delivery, March 2011, Informa Healthcare

    Prof Yogeshvar Kalia

  106. Comparing metoclopramide electrotransport kinetics in vitro and in vivo

    Article • European Journal of Pharmaceutical Sciences, October 2010, Elsevier

    Prof Yogeshvar Kalia

  107. Development and validation of a rapid high-performance liquid chromatography method for the quantification of exenatide

    Article • Biomedical Chromatography, September 2010, Wiley

    Prof Yogeshvar Kalia

  108. Effect of controlled laser microporation on drug transport kinetics into and across the skin

    Article • Journal of Controlled Release, August 2010, Elsevier

    Prof Yogeshvar Kalia

  109. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6kDa) across intact porcine and human skins

    Article • Journal of Controlled Release, August 2010, Elsevier

    Prof Yogeshvar Kalia

  110. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: Effect of experimental parameters and skin type on drug stability and transport kinetics

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2010, Elsevier

    Prof Yogeshvar Kalia

  111. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: Effect of experimental conditions and a comparison with other enhancement strategies

    Article • European Journal of Pharmaceutical Sciences, March 2010, Elsevier

    Prof Yogeshvar Kalia

  112. Development and validation of an analytical method for the quantification of cytochrome c in skin transport studies

    Article • Biomedical Chromatography, November 2009, Wiley

    Prof Yogeshvar Kalia

  113. Stability of triptorelin in the presence of dermis and epidermis

    Article • International Journal of Pharmaceutics, August 2009, Elsevier

    Prof Yogeshvar Kalia

  114. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo

    Article • European Journal of Pharmaceutics and Biopharmaceutics, June 2009, Elsevier

    Prof Yogeshvar Kalia

  115. In vitro evaluation of the effect of electrotreatment on skin permeability

    Article • Journal of Cosmetic Dermatology, June 2008, Wiley

    Prof Yogeshvar Kalia

  116. Effect of propylene glycol on ibuprofen absorption into human skin in vivo

    Article • Journal of Pharmaceutical Sciences, January 2008, Elsevier

    Prof Yogeshvar Kalia

  117. In Vivo Methods for the Assessment of Topical Drug Bioavailability

    Article • Pharmaceutical Research, November 2007, Springer Science + Business Media

    Prof Yogeshvar Kalia

  118. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate

    Article • European Journal of Pharmaceutics and Biopharmaceutics, May 2007, Elsevier

    Prof Yogeshvar Kalia

  119. Transdermal Delivery of Cytochrome C—A 12.4 kDa Protein—Across Intact Skin by Constant–Current Iontophoresis

    Article • Pharmaceutical Research, April 2007, Springer Science + Business Media

    Prof Yogeshvar Kalia

  120. Dermatopharmacokinetic Prediction of Topical Drug Bioavailability In Vivo

    Article • Journal of Investigative Dermatology, April 2007, Elsevier

    Prof Yogeshvar Kalia

  121. Ibuprofen Transport into and through Skin from Topical Formulations: In Vitro–In Vivo Comparison

    Article • Journal of Investigative Dermatology, January 2007, Elsevier

    Prof Yogeshvar Kalia

  122. Structure–permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis

    Article • European Journal of Pharmaceutical Sciences, September 2006, Elsevier

    Prof Yogeshvar Kalia

  123. Topical Iontophoresis of Valaciclovir Hydrochloride Improves Cutaneous Aciclovir Delivery

    Article • Pharmaceutical Research, July 2006, Springer Science + Business Media

    Prof Yogeshvar Kalia

  124. Pig Ear Skin ex Vivo as a Model for in Vivo Dermatopharmacokinetic Studies in Man

    Article • Pharmaceutical Research, July 2006, Springer Science + Business Media

    Prof Yogeshvar Kalia

  125. New Developments in Topical Antifungal Therapy

    Article • American Journal of Drug Delivery, January 2006, Springer Science + Business Media

    Prof Yogeshvar Kalia

  126. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility

    Article • Journal of Pharmaceutical Sciences, December 2005, Elsevier

    Prof Yogeshvar Kalia

  127. Effect of amino acid sequence on transdermal iontophoretic peptide delivery

    Article • European Journal of Pharmaceutical Sciences, December 2005, Elsevier

    Prof Yogeshvar Kalia

  128. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin

    Article • Journal of Controlled Release, November 2005, Elsevier

    Prof Yogeshvar Kalia

  129. Yannic B. Schuetz, Aarti Naik, Richard H. Guy, Evelyne Vuaridel, Yogeshvar N. Kalia. Transdermal Iontophoretic Delivery of Triptorelin In Vitro. 94:2175-2182, 2005

    Article • Journal of Pharmaceutical Sciences, November 2005, Elsevier

    Prof Yogeshvar Kalia

  130. Transdermal Iontophoretic Delivery of Triptorelin in Vitro

    Article • Journal of Pharmaceutical Sciences, October 2005, Elsevier

    Prof Yogeshvar Kalia

  131. Effect of Charge and Molecular Weight on Transdermal Peptide Delivery by Iontophoresis

    Article • Pharmaceutical Research, September 2005, Springer Science + Business Media

    Prof Yogeshvar Kalia

  132. Transdermal Iontophoretic Delivery of Vapreotide Acetate AcrossPorcine Skin in Vitro

    Article • Pharmaceutical Research, August 2005, Springer Science + Business Media

    Prof Yogeshvar Kalia

  133. Skin permeation enhancement by sucrose esters: A pH-dependent phenomenon

    Article • International Journal of Pharmaceutics, June 2005, Elsevier

    Prof Yogeshvar Kalia

  134. Emerging strategies for the transdermal delivery of peptide and protein drugs

    Article • Expert Opinion on Drug Delivery, May 2005, Informa Healthcare

    Prof Yogeshvar Kalia

  135. Development of an in vitro model for premature neonatal skin: Biophysical characterization using transepidermal water loss

    Article • Journal of Pharmaceutical Sciences, December 2004, Elsevier

    Prof Yogeshvar Kalia

  136. Assessment of Topical Bioavailability in vivo: The Importance of Stratum corneum Thickness

    Article • Skin Pharmacology and Physiology, November 2004, Karger Publishers

    Prof Yogeshvar Kalia

  137. Iontophoretic Transport across the Skin

    Article • Skin Pharmacology and Physiology, November 2004, Karger Publishers

    Prof Yogeshvar Kalia

  138. Enhancement of Topical Delivery from Biodegradable Nanoparticles

    Article • Pharmaceutical Research, October 2004, Springer Science + Business Media

    Prof Yogeshvar Kalia

  139. Skin penetration and distribution of polymeric nanoparticles

    Article • Journal of Controlled Release, September 2004, Elsevier

    Prof Yogeshvar Kalia

  140. Visualization of skin penetration using confocal laser scanning microscopy

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2004, Elsevier

    Prof Yogeshvar Kalia

  141. Porcine Ear Skin as a Model for the Assessment of Transdermal Drug Delivery to Premature Neonates

    Article • Pharmaceutical Research, August 2004, Springer Science + Business Media

    Prof Yogeshvar Kalia

  142. Iontophoretic drug delivery

    Article • Advanced Drug Delivery Reviews, March 2004, Elsevier

    Prof Yogeshvar Kalia

  143. Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo

    Article • International Journal of Pharmaceutics, March 2004, Elsevier

    Prof Yogeshvar Kalia

  144. Ultrasound‐Enhanced Transdermal Transport

    Article • Journal of Pharmaceutical Sciences, June 2003, Elsevier

    Prof Yogeshvar Kalia

  145. Skin Permeability Enhancement by Low Frequency Sonophoresis: Lipid Extraction and Transport Pathways

    Article • Journal of Pharmaceutical Sciences, June 2003, Elsevier

    Prof Yogeshvar Kalia

  146. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis

    Article • Journal of Controlled Release, February 2003, Elsevier

    Prof Yogeshvar Kalia

  147. Article • Pharmaceutical Research, January 2003, Springer Science + Business Media

    Prof Yogeshvar Kalia

  148. Biophysical Study of Porcine Ear Skin In Vitro and Its Comparison to Human Skin In Vivo

    Article • Journal of Pharmaceutical Sciences, November 2002, Elsevier

    Prof Yogeshvar Kalia

  149. Reverse iontophoretic monitoring in premature neonates: feasibility and potential

    Article • Journal of Controlled Release, May 2002, Elsevier

    Prof Yogeshvar Kalia

  150. In vivo assessment of skin electroporation using square wave pulses

    Article • Journal of Controlled Release, February 2002, Elsevier

    Prof Yogeshvar Kalia

  151. Post-iontophoresis recovery of human skin impedance in vivo

    Article • European Journal of Pharmaceutics and Biopharmaceutics, January 2002, Elsevier

    Prof Yogeshvar Kalia

  152. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion

    Article • Journal of Controlled Release, September 2001, Elsevier

    Prof Yogeshvar Kalia

  153. Passive skin penetration enhancement and its quantification in vitro

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2001, Elsevier

    Prof Yogeshvar Kalia

  154. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery

    Article • International Journal of Pharmaceutics, August 2001, Elsevier

    Prof Yogeshvar Kalia

  155. Modeling transdermal drug release

    Article • Advanced Drug Delivery Reviews, June 2001, Elsevier

    Prof Yogeshvar Kalia

  156. Enhanced skin permeation of a lipophilic drug using supersaturated formulations

    Article • Journal of Controlled Release, June 2001, Elsevier

    Prof Yogeshvar Kalia

  157. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo

    Article • Journal of Pharmacy and Pharmacology, June 2001, Wiley

    Prof Yogeshvar Kalia

  158. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo

    Article • International Journal of Pharmaceutics, May 2001, Elsevier

    Prof Yogeshvar Kalia

  159. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum

    Article • Journal of Controlled Release, April 2001, Elsevier

    Prof Yogeshvar Kalia

  160. Factors and strategies for improving buccal absorption of peptides

    Article • European Journal of Pharmaceutics and Biopharmaceutics, March 2001, Elsevier

    Prof Yogeshvar Kalia

  161. Article • Pharmaceutical Research, January 2001, Springer Science + Business Media

    Prof Yogeshvar Kalia

  162. Article • Pharmaceutical Research, January 2001, Springer Science + Business Media

    Prof Yogeshvar Kalia

  163. Article • Pharmaceutical Research, January 2001, Springer Science + Business Media

    Prof Yogeshvar Kalia

  164. Article • Pharmaceutical Research, January 2001, Springer Science + Business Media

    Prof Yogeshvar Kalia

  165. Recovery of human skin impedance in vivo after lontophoresis: Effect of metal ions

    Article • AAPS PharmSci, September 2000, American Association of Pharmaceutical Scientists (AAPS)

    Prof Yogeshvar Kalia

  166. Transdermal drug delivery: overcoming the skin’s barrier function

    Article • Pharmaceutical Science & Technology Today, September 2000, Elsevier

    Prof Yogeshvar Kalia

  167. Iontophoresis: electrorepulsion and electroosmosis

    Article • Journal of Controlled Release, February 2000, Elsevier

    Prof Yogeshvar Kalia

  168. Article • Pharmaceutical Research, January 1999, Springer Science + Business Media

    Prof Yogeshvar Kalia

  169. Ion mobility across human stratum corneum in vivo

    Article • Journal of Pharmaceutical Sciences, December 1998, Elsevier

    Prof Yogeshvar Kalia

  170. Development of Skin Barrier Function in Premature Infants

    Article • Journal of Investigative Dermatology, August 1998, Elsevier

    Prof Yogeshvar Kalia

  171. TRANSDERMAL DRUG DELIVERY

    Article • Dermatologic Clinics, April 1998, Elsevier

    Prof Yogeshvar Kalia

  172. Article • Pharmaceutical Research, January 1998, Springer Science + Business Media

    Prof Yogeshvar Kalia

  173. Mechanisms of oral permeation enhancement

    Article • International Journal of Pharmaceutics, October 1997, Elsevier

    Prof Yogeshvar Kalia

  174. Transdermal therapy and diagnosis by iontophoresis

    Article • Trends in Biotechnology, August 1997, Elsevier

    Prof Yogeshvar Kalia

  175. Characterization of the permeability barrier of human skin in vivo

    Article • Proceedings of the National Academy of Sciences, February 1997, Proceedings of the National Academy of Sciences

    Prof Yogeshvar Kalia

  176. Interaction between penetration enhancers and iontophoresis: effect on human skin impedance in vivo

    Article • Journal of Controlled Release, February 1997, Elsevier

    Prof Yogeshvar Kalia

  177. Article • Pharmaceutical Research, January 1997, Springer Science + Business Media

    Prof Yogeshvar Kalia

  178. Transdermal delivery of peptides by iontophoresis

    Article • Nature Biotechnology, December 1996, Nature

    Prof Yogeshvar Kalia

  179. Article • Pharmaceutical Research, January 1996, Springer Science + Business Media

    Prof Yogeshvar Kalia

  180. Article • Pharmaceutical Research, January 1995, Springer Science + Business Media

    Prof Yogeshvar Kalia

  181. Protein-protein recognition mediated by a mini-protein domain: Possible evolutionary significance

    Article • Trends in Biochemical Sciences, September 1994, Elsevier

    Prof Yogeshvar Kalia

  182. Amperometric enzyme electrodes

    Article • Journal of Electroanalytical Chemistry, March 1992, Elsevier

    Prof Yogeshvar Kalia